Lv1
10 积分 2025-06-06 加入
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
5小时前
待确认
SHR-A1403, a novel c-Met antibody-drug conjugate, exerts encouraging anti-tumor activity in c-Met-overexpressing models
26天前
已完结
An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer
1个月前
已完结
Orderly Regulation of Macrophages and Fibroblasts by Axl in Bleomycin‐Induced Pulmonary Fibrosis in Mice
1个月前
已完结
Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models
1个月前
已完结
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH
1个月前
已完结
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis
1个月前
已完结
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
2个月前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
2个月前
已完结
Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations
3个月前
已完结
皖公网安备34019202002308
